|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Innovations in Diagnostics: Next generation molecular and point-of-care diagnostics driving personalized healthcare |
|
|
|
|
€ 2 300,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Septembre 2006 |
Taille du document : |
126 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 52 pages | Août 2004 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,life sciences,hospital,...
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,mauritius,france,india |
| |
|
|
|
|
| 46 pages | Septembre 2000 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,dentists,private healthcare
|
| Research
focus: |
market size and estimates,market segmentation, |
| Geographic
focus: |
united kingdom,usa,japan,philippines,germany,... |
| |
|
|
|
|
| 78 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,healthcare informatics,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,canada,united kingdom,australia |
| |
|
|
|
|
| 52 pages | Janvier 2007 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,healthcare informatics,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
usa,france,united kingdom,canada,australia,china |
| |
|
|
|
|
| 84 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,dentists,life sciences,...
|
| Research
focus: |
demand analysis,competition analysis, |
| Geographic
focus: |
usa,mexico,india,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Pharmaceutical Packaging Market
80 pages | Avril 2002 |
This report will enable you to:Analyse the size of the UK market for pharmaceutical packaging between 1997 and 2006, by type: - cartons - containers - labels and leaflets - blister & strip p |
1 479,00 €
|
| |
| |
Chinese Markets for OTC Drugs
220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend |
3 500,00 €
|
| |
| |
The Generics Outlook 2001
242 pages | Février 2001 |
“By the year 2004, it is expected that the value of the total western European generics sector may have risen to $19 billion, representing almost 15% of allpharmaceuticals.
In the USA, the val |
955,00 €
|
| |
| |
Healthcare In Southern Ireland
40 pages | Mai 2000 |
The Republic Of Ireland Presentation Includes:- The Structure Of The Health Service In The Republic Of Ireland- Capital Expenditure On Health Care In The Republic Of Ireland- Number Of Publicly Funded |
327,00 €
|
| |
| |
Generic Pharmaceutical Outlook 1998-2008
190 pages | Octobre 1998 |
Currently estimated to account for approximately 11% of Global pharmaceutical sales, this figure looks set to rise dramatically as branded drugs come off-patent within the next decade.
Imminent |
795,00 €
|
| |
| |
OTC Analgesics in Germany
15 pages | Juillet 2002 |
The German market for OTC analgesics growth not so rapidly and reached a value of Euro 772 million (US$ 729 million) in 2001, an increase of 1.6% on the previous year.
Over the review period, the m |
198,00 €
|
| |
| |
Healthcare: Germany
106 pages | Octobre 2000 |
Compare the changes in expenditure between the different healthcare sectors in Germany · Understand the main factors affecting demand for healthcare services in Germany · Examine the |
578,54 €
|
| |
| |
Pharmaceutical Mergers & Aquisitions: the third wave
160 pages | Février 1999 |
Historical assessment : The report identifies the factors that have driven the two historical waves of M&A activity, and analyses the relative importance of these factors through case studies.
795,00 €
|
|
| |
| |
OTC Cough and Cold Remedies in Germany
15 pages | Juillet 2002 |
The German market for OTC cough and cold remedies reached a value of Euro 972 million (US$ 918 million) in 2001, up 0.4% on the previous year.
During the review period, the market grew by 9.4%, an |
198,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Innovations in Diagnostics: Next generation molecular and point-of-care diagnostics driving personalized healthcare |
|
|
The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare market, allowing more tests to be performed at the point-of-care and facilitating the shift towards personalized medicine. “Innovation in Diagnostics” examines the advances in the rapidly growing field of molecular technologies that are enabling personalized healthcare to move into mainstream medicine. New opportunities in infectious disease testing, molecular oncology and pharmacogenomics are explored in detail, enabling you to understand the forces that are driving in vitro diagnostics (IVDs) into centre stage of the healthcare arena. Understand the changing relationship between IVD companies and the pharmaceutical industry, assess the convergence of IVDs and medical imaging, and develop an understanding of new technologies that will influence diagnostic product development and drug development programs.
|
|
The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare market, allowing more tests to be performed at the point-of-care and facilitating the shift towards personalized medicine. “Innovation in Diagnostics” examines the advances in the rapidly growing field of molecular technologies that are enabling personalized healthcare to move into mainstream medicine. New opportunities in infectious disease testing, molecular oncology and pharmacogenomics are explored in detail, enabling you to understand the forces that are driving in vitro diagnostics (IVDs) into centre stage of the healthcare arena. Understand the changing relationship between IVD companies and the pharmaceutical industry, assess the convergence of IVDs and medical imaging, and develop an understanding of new technologies that will influence diagnostic product development and drug development programs.
|
|
|
PPLSEN
|
|
|
|
|
